DOVEINTEL
MI

MIRIAM

cure cancer
Solanapump.funLaunched 5h agopumpfun
GCCbU45UWcZ8qYQp9HtRrwAyhR9z3rjhYiuW2YshpumpExplorer
42/ 100
Dove Trust Score
High risk

Serious red flags

Confidence70%

How much of the verification rubric we could actually evaluate. Unknown data never counts as safe.

Contract safety83 · 4/4
Liquidity & market62 · 7/7
Holder distribution66 · 5/5
Identity & community23 · 2/2
Provenance & reputation56 · 2/2
Dove brief

cure cancer ($MIRIAM) on Solana has been trading for 5 h via pump.fun.

Dove Trust Score 42/100: High risk (confidence 70%).

Strengths: Not flagged as rugged. Mint authority is revoked: supply is fixed. Liquidity sits on the launchpad's bonding curve and cannot be withdrawn by the creator.

Concerns: Deployer launched 15 other tokens that scored as high-risk. $1.0K: very thin, easily manipulated. Creator history of rugged tokens

Multiple serious red flags. The structure of this token resembles patterns commonly seen in rug pulls.

Ask Dove about this token
Red flags & warnings
  • Deployer reputation high
    Deployer launched 15 other tokens that scored as high-risk.
  • Independent analyser findings med
    Creator history of rugged tokens
  • Liquidity depth med
    $1.0K: very thin, easily manipulated.
  • Price behaviour med
    Price down 100% in 24h: consistent with a rug or collapse.
  • Holder count med
    Only 3 holders.
  • Social presence low
    No social channels linked.
  • Largest holder
    Largest wallet holds 10.0%.
  • Official website
    No official website linked.
Price
$0.0₈1186
-100.0%
Liquidity
$1.0K
Market cap
$1
FDV $1
Volume 24h
$389
Holders
3
Trades 24h
186
49% buys
1h change
-69.5%
Market & trust history
History builds as the crawler re-checks this token. Come back in a few minutes.

Verification report

Contract safety
4 checks
Liquidity & market
7 checks
Holder distribution
5 checks
Identity & community
2 checks
Provenance & reputation
2 checks

More from this deployer

Last verified 1 minutes ago · Sources: jupiter, dexscreener · Automated analysis, not financial advice. How scoring works